High Net Worth Advisory Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
High Net Worth Advisory Group's LLY Position: Q2 2026 in Review
High Net Worth Advisory Group reduced its Eli Lilly (LLY) stake by 6.4% in Q2 2026, selling an estimated $158K and leaving 2,256 shares worth $2.71M. The position accounts for 0.57% of the portfolio, ranked #44.
High Net Worth Advisory Group first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. The position peaked at $4.58M in Q2 2024. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- High Net Worth Advisory Group held 2,256 shares of Eli Lilly worth $2.71M as of Q2 2026.
- High Net Worth Advisory Group sold 155 Eli Lilly shares in Q2 2026, an estimated $158K.
- Eli Lilly made up 0.57% of High Net Worth Advisory Group's portfolio in Q2 2026, its #44 holding.
- High Net Worth Advisory Group first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
- High Net Worth Advisory Group's Eli Lilly position peaked at $4.58M in Q2 2024.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on High Net Worth Advisory Group's 13F filing for Q2 2026, filed 29 Jul 2026.